Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ucommune International Ltd.

1.09
+0.03152.98%
Post-market: 1.090.00000.00%18:51 EDT
Volume:7.75K
Turnover:8.32K
Market Cap:2.31M
PE:-0.13
High:1.09
Open:1.06
Low:1.06
Close:1.06
Loading ...

Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2025

GlobeNewswire
·
02 May

Bavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for Persons Aged 12 and Older in the United Kingdom

GlobeNewswire
·
02 May

Caledonia Mining Corporation Plc: Notice of Q1 2025 Results and Investor Presentation

GlobeNewswire
·
02 May

ING posts 1Q2025 net result of €1,455 million, with strong growth in customer balances and fee income

GlobeNewswire
·
02 May

Press Release: ING posts 1Q2025 net result of EUR1,455 million, with strong growth in customer balances and fee income

Dow Jones
·
02 May

New Clinical Data Presented about VIVO at the 46th Annual Heart Rhythm Association Conference

GlobeNewswire
·
01 May

Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia

GlobeNewswire
·
01 May

Getlink: Half-yearly Review of the Liquidity Contract

Business Wire
·
30 Apr

Pharming Group announces the 2025 Annual General Meeting of Shareholders and the nomination of a new Non-Executive Director

GlobeNewswire
·
30 Apr

DePIN Project Kairos announces the completion of its seed round financing, with Vertex Capital, HKIFS, and Oaktree Capital co-leading the investment.

Blockbeats
·
30 Apr

Technip Energies First Quarter 2025 Financial Results

GlobeNewswire
·
30 Apr

Theraclion Announces Financial Results 2024 and Reviews Progress

Business Wire
·
30 Apr

RBC Capital Keeps Their Buy Rating on Shell (UK) (SHEL)

TIPRANKS
·
29 Apr

Amundi: Results for the First quarter of 2025 - Record inflows at +€31bn

GlobeNewswire
·
29 Apr

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

GlobeNewswire
·
29 Apr

IBA – TRANSPARENCY NOTIFICATION

GlobeNewswire
·
29 Apr

BEYONTTRA® (acoramidis), the First Near-complete TTR Stabilizer (≥90%), Approved by the UK Medicines and Healthcare Products Regulatory Agency to Treat ATTR-CM

GlobeNewswire
·
28 Apr

Shell Executes Share Buyback to Enhance Capital Strategy

TIPRANKS
·
26 Apr

HUSQVARNA AB: INTERIM REPORT JANUARY - MARCH 2025

PR Newswire
·
24 Apr

Blaize to Report First Quarter 2025 Financial Results on May 14, 2025

Business Wire
·
24 Apr